IMAQUA Scales Global Reach: Bringing Expert Shrimp Health and Nutrition Solutions to Southeast Asia and Latin America

Imaqua Global Expension

Global Aquaculture Industry Announcement

IMAQUA is a premier private contract research organization established in 2015, built upon a foundational legacy of more than 30 years of cutting-edge academic research on shrimp health with Universities such as Ghent University (Belgium) and the global shrimp farming industry innovators. As an independent organization driven strictly by quality, reliability, and confidentiality, IMAQUA is exclusively dedicated to supporting companies that pioneer shrimp health and nutrition products, develop disease-resistant shrimp genetic lines, and innovate sustainable shrimp farming concepts.

By prioritizing client-specific R&D needs and providing completely impartial, objective advice, IMAQUA uses proprietary testing models and state-of-the-art facilities to produce high-quality data under the highest quality standards. Ultimately, by advancing individual client projects, IMAQUA actively promotes and contributes to the sustainable growth of the global shrimp aquaculture industry.

Strategic Horizons: Establishing a Local Presence in Southeast Asia and Latin America

Recognizing that sustainable shrimp production requires localized agility and real-time response, IMAQUA is proud to announce the official expansion of its operations into two strategically located aquaculture hubs: Vietnam and Brazil. This physical and operational expansion represents a significant step forward in providing seamless, direct support to regional producers, health innovators, and feed manufacturers.

Why This Matters for Regional Aquaculture

By establishing a direct presence in Southeast Asia and Latin America, IMAQUA eliminates logistical friction, bridges geographic barriers, and brings world-class scientific rigor right to the heart of regional farming ecosystems. Local stakeholders can now leverage advanced scientific methodologies tailored precisely to local environmental variables, pathogens, shrimp breeding lines and farming conditions.

Comprehensive Diagnostic and Testing Ecosystem

With this international expansion, IMAQUA introduces a robust, specialized portfolio of services on the ground in Southeast Asia and Latin America, designed to bring scientific precision, and commercial validation to product development:

  • Diagnostics & PCR: Advanced diagnostic processing using state-of-the-art Polymerase Chain Reaction (PCR) and nanopore sequencing workflows . This provides rapid, ultra-precise pathogen screening and quantification to detect epidemiological shifts early and accurately, enabling the timely implementation of control measures.
  • In Vivo Trials: Using proprietary, specialized testing infrastructure and standardized testing models, IMAQUA delivers optimal experimental designs to validate the physiological effects of products in vivo, assuring reproducibility under local, controlled conditions and well-defined standard operating procedures.
  • Prevalence Campaigns: Proactive field mapping and epidemiological screening campaigns to monitor regional disease baselines. These insights empower companies to evaluate true pathogen pressures and position nutritional, health or genetic solutions effectively.

A Partnership Driven by Scientific Versatility

At IMAQUA, the best approach to quality service is built upon close, continuous interaction throughout all stages of product development. Every client is advised individually depending on their specific R&D goals and product particularities. By maintaining rigorous standard operating procedures (SOPs) alongside maximum operational flexibility, IMAQUA seamlessly accommodates complex testing and validation requests. The powerful combination of solid scientific and technical knowledge alongside the versatility of high-tech infrastructure ensures that every test delivers high-quality, reproducible results offering superior value for money.

Discuss Your Testing Capabilities Today

Whether you want to explore advanced diagnostics, deploy a field prevalence campaign, or initiate specialized in vivo trials for your specific product in Europe, Southeast Asia or Latin America, our global expert team is at your disposal. We are fully dedicated to finding the best solutions for reaching your goals.